Mehar C. Sharma

New Delhi, DL 110029, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Retraction Note: Study of β-catenin and BRAF alterations in adamantinomatous and papillary craniopharyngiomas: mutation analysis with immunohistochemical correlation in 54 cases.

Retraction Note: Study of β-catenin and BRAF alterations in adamantinomatous and papillary craniopharyngiomas: mutation analysis with immunohistochemical correlation in 54 cases.

Journal: Journal of neuro-oncology

Published: May 26, 2026

Unraveling the miRNA-EMT-stemness interplay in fusion-positive supratentorial ependymomas: Identifying therapeutic vulnerabilities.

Unraveling the miRNA-EMT-stemness interplay in fusion-positive supratentorial ependymomas: Identifying therapeutic vulnerabilities.

Journal: Biochemical and biophysical research communications

Published: November 06, 2025

Astroblastoma: A molecularly defined entity, its clinico-radiological & pathological analysis of eight cases and review of literature.

Astroblastoma: A molecularly defined entity, its clinico-radiological & pathological analysis of eight cases and review of literature.

Journal: Pathology, research and practice

Published: August 07, 2024

MYCN immunohistochemistry as surrogate marker for MYCN-amplified spinal ependymomas.

MYCN immunohistochemistry as surrogate marker for MYCN-amplified spinal ependymomas.

Journal: Human cell

Published: July 10, 2023

TTF-1: A Well-Favored Addition to the Immunohistochemistry Armamentarium as a Diagnostic Marker of SEGA.

TTF-1: A Well-Favored Addition to the Immunohistochemistry Armamentarium as a Diagnostic Marker of SEGA.

Journal: World neurosurgery

Published: September 16, 2021

Correction to: EZH2 inhibitory protein (EZHIP/Cxorf67) expression correlates strongly with H3K27me3 loss in posterior fossa ependymomas and is mutually exclusive with H3K27M mutations.

Correction to: EZH2 inhibitory protein (EZHIP/Cxorf67) expression correlates strongly with H3K27me3 loss in posterior fossa ependymomas and is mutually exclusive with H3K27M mutations.

Journal: Brain tumor pathology

Published: January 09, 2021

C19MC amplification and expression of Lin28A and Olig2 in the classification of embryonal tumors of the central nervous system: A 14-year retrospective study from a tertiary care center.

C19MC amplification and expression of Lin28A and Olig2 in the classification of embryonal tumors of the central nervous system: A 14-year retrospective study from a tertiary care center.

Journal: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery

Published: June 08, 2020

Granular Cell Astrocytoma: A Diagnostic Conundrum.

Granular Cell Astrocytoma: A Diagnostic Conundrum.

Journal: World neurosurgery

Published: June 04, 2020

EZH2 inhibitory protein (EZHIP/Cxorf67) expression correlates strongly with H3K27me3 loss in posterior fossa ependymomas and is mutually exclusive with H3K27M mutations.

EZH2 inhibitory protein (EZHIP/Cxorf67) expression correlates strongly with H3K27me3 loss in posterior fossa ependymomas and is mutually exclusive with H3K27M mutations.

Journal: Brain tumor pathology

Published: May 28, 2020

SMARCB1 (INI1)-deficient thyroid carcinoma: A novel entity expanding the spectrum of tumors with INI1 loss.

SMARCB1 (INI1)-deficient thyroid carcinoma: A novel entity expanding the spectrum of tumors with INI1 loss.

Journal: Pathology, research and practice

Published: October 13, 2019

mTOR pathway activation in focal cortical dysplasia.

mTOR pathway activation in focal cortical dysplasia.

Journal: Annals of diagnostic pathology

Published: August 23, 2019

Clinicopathological evaluation of PD-L1 expression and cytotoxic T-lymphocyte infiltrates across intracranial molecular subgroups of ependymomas: are these tumors potential candidates for immune check-point blockade?

Clinicopathological evaluation of PD-L1 expression and cytotoxic T-lymphocyte infiltrates across intracranial molecular subgroups of ependymomas: are these tumors potential candidates for immune check-point blockade?

Journal: Brain tumor pathology

Published: May 21, 2019

Showing 1-12 of 37

Last Updated: 09/26/2026